Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 01, 2019

SELL
$58.04 - $66.99 $1.92 Million - $2.21 Million
-33,000 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$35.52 - $62.62 $1.17 Million - $2.07 Million
33,000 New
33,000 $2.17 Million
Q4 2018

Feb 12, 2019

SELL
$35.43 - $56.29 $1.17 Million - $1.86 Million
-33,000 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$44.22 - $75.47 $530,640 - $905,640
12,000 Added 57.14%
33,000 $0
Q2 2018

Aug 14, 2018

BUY
$72.38 - $92.5 $940,939 - $1.2 Million
13,000 Added 162.5%
21,000 $1.66 Million
Q1 2018

May 03, 2018

SELL
$69.46 - $88.57 $798,789 - $1.02 Million
-11,500 Reduced 58.97%
8,000 $690,000
Q3 2017

Nov 06, 2017

BUY
$80.87 - $91.08 $1.58 Million - $1.78 Million
19,500
19,500 $1.63 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.